α-Glucosidase inhibitors and their synthesis from a...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07071341

ABSTRACT:
The present invention provides novel α-glucosidase inhibitory compound (−)-mesquitol and its analogs isolated in significant yield from traditional medicinal plantDichrostachys cinereaand further modification of (−)-mesquitol to enhance the α-glucosidase inhibitory potential; the invention also identifies the usage of (−)-mesquitol and its analogues, based on their α-glucosidase inhibitory activity, as broad based potential therapeutics as antihyperglycernic, antidiabatic, antiobesity, antiviral, anticancer, immunestimulants and the like.

REFERENCES:
Collins, FM ‘Current treatment approaches to type 2 diabetes mellitus: success and shortcomings’ PMID: 12408409 (2002).
Scheen, AJ ‘Treatment of diabetes in patients with severe obesity’ Biomed & Pharmacother (2000) 54:74-79.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

α-Glucosidase inhibitors and their synthesis from a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with α-Glucosidase inhibitors and their synthesis from a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α-Glucosidase inhibitors and their synthesis from a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3586766

All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.